
Ac-Pro-Gly-Pro-OH
CAS No. 292171-04-1
Ac-Pro-Gly-Pro-OH( —— )
Catalog No. M36655 CAS No. 292171-04-1
Ac-Pro-Gly-Pro-OH is an acetyl-modified tripeptide compound that acts as a CXCR2 agonist, exhibiting bactericidal and anti-inflammatory activities.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 58 | Get Quote |
![]() ![]() |
5MG | 82 | Get Quote |
![]() ![]() |
10MG | 119 | Get Quote |
![]() ![]() |
25MG | 182 | Get Quote |
![]() ![]() |
50MG | 273 | Get Quote |
![]() ![]() |
100MG | 412 | Get Quote |
![]() ![]() |
500MG | 954 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameAc-Pro-Gly-Pro-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionAc-Pro-Gly-Pro-OH is an acetyl-modified tripeptide compound that acts as a CXCR2 agonist, exhibiting bactericidal and anti-inflammatory activities.
-
DescriptionAc-Pro-Gly-Pro-OH is an endogenous degradation product of extracellular collagen and can be used as CXCR2 agonist. Ac-Pro-Gly-Pro-OH elicits bactericidal activity and inhibits lung inflammation, reducing immune cell apoptosis. Ac-Pro-Gly-Pro-OH enhances the production of type 1 cytokines (IFN-γ and IL-12) but inhibits the production of proinflammatory cytokines. Ac-Pro-Gly-Pro-OH has the potential for the research of sepsis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis | CXCR | Antibiotic
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number292171-04-1
-
Formula Weight311.33
-
Molecular FormulaC14H21N3O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NCC(=O)N1[C@H](C(O)=O)CCC1)(=O)[C@H]2N(C(C)=O)CCC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Patel DF, et al The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease. Eur Respir Rev. 2018 Jun 27;27(148):180017.?
molnova catalog



related products
-
TJ08
TJ08 is a 1,2,5-trisubstituted benzimidazole derivative with anticancer properties that effectively induces G1/S phase blockade while promoting apoptotic effects in a variety of cancer cells.
-
BC 11 hydrobromide
BC 11 hydrobromide is a selective TMPRSS2 and urokinase (uPA) inhibitor.BC-11 induces diminished mitochondrial activity, promotes reactive oxygen species production, and promotes apoptosis, and can be used in the study of breast cancer.
-
SCFSkp2-IN-2
SCFSkp2-IN-2, a Skp2 inhibitor, exhibits a dissociation constant (K_D) of 28.77 μM. It demonstrates antitumor activities by inducing apoptosis in non-small cell lung cancer (NSCLC) cells.